Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

£18.5m will be invested in training the next generation of bioscience leaders at Oxford University to tackle global challenges such as food security and animal health.

£12.5m of funding from the Biotechnology and Biological Sciences Research Council (BBSRC) combined with over £6m from the University, colleges, and partner organisations will support up to 180 doctoral students over the next five years as part of the Oxford Interdisciplinary Bioscience Doctoral Training Partnership (DTP).

The funding has been awarded as part of a national investment of £125m over five years from BBSRC announced by Business Secretary Vince Cable on 3 October 2014 at an event in Edinburgh. Business Secretary Vince Cable said: 'The UK punches far beyond its weight in science and innovation globally, which is a credit to our talented scientists and first-class universities. This new funding will safeguard Britain's status as a world leader in life sciences and agricultural technology.'

Read more

Similar stories

University of Oxford launches new public awareness campaign for Neurodevelopmental Disorders

The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.

Magdalen College lit up for Rare Disease Day

Magdalen College Chapel was lit up in the colours of Rare Disease Day last week, as part of the global Chain of Lights initiative.

HRH The Duke of Gloucester Visits University of Oxford’s Cutting-Edge Vaccine Facilities

His Royal Highness the Duke of Gloucester visited the University of Oxford on Thursday 24th July to tour two of its leading medical research centres: the Clinical BioManufacturing Facility and the laboratories of the Oxford Vaccine Group (OVG) and Pandemic Sciences Institute (PSI), located on the University’s Old Road Campus.

New study shows that early support for children living in marginalised communities can improve their developmental outcomes

Research by experts at the Department of Paediatrics, and published in the European Journal of Paediatrics shows that early interventions of support to the development of children living in disadvantaged settings, can significantly improve their neurodevelopmental outcomes during early childhood.

How the Information Security Office and the National Cyber Security Centre keeps Oxford's research secure post-pandemic

Oxford University's Information Security Office (InfoSec) invited the NCSC to Oxford to thank them for the work they did that kept Oxford’s vaccine research secure.

Oxford hosts Belgian vaccine experts

Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.

Similar stories

University of Oxford launches new public awareness campaign for Neurodevelopmental Disorders

The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.

Magdalen College lit up for Rare Disease Day

Magdalen College Chapel was lit up in the colours of Rare Disease Day last week, as part of the global Chain of Lights initiative.

HRH The Duke of Gloucester Visits University of Oxford’s Cutting-Edge Vaccine Facilities

His Royal Highness the Duke of Gloucester visited the University of Oxford on Thursday 24th July to tour two of its leading medical research centres: the Clinical BioManufacturing Facility and the laboratories of the Oxford Vaccine Group (OVG) and Pandemic Sciences Institute (PSI), located on the University’s Old Road Campus.

New study shows that early support for children living in marginalised communities can improve their developmental outcomes

Research by experts at the Department of Paediatrics, and published in the European Journal of Paediatrics shows that early interventions of support to the development of children living in disadvantaged settings, can significantly improve their neurodevelopmental outcomes during early childhood.

How the Information Security Office and the National Cyber Security Centre keeps Oxford's research secure post-pandemic

Oxford University's Information Security Office (InfoSec) invited the NCSC to Oxford to thank them for the work they did that kept Oxford’s vaccine research secure.

Oxford hosts Belgian vaccine experts

Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.